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Russian Academy of Sciences, Moscow, RussiaABSTRACT A hallmark of the common Alzheimer’s disease (AD) is the pathological conversion of its amphiphatic amyloid-b
(Ab) peptide into neurotoxic aggregates. In AD patients, these aggregates are often found to be tightly associated with neuronal
GM1 ganglioside lipids, suggesting an involvement of GM1 not only in aggregate formation but also in neurotoxic events. Signif-
icant interactions were found between micelles made of newly synthesized fluorescent GM1 gangliosides labeled in the polar
headgroup or the hydrophobic chain and Ab(1–40) peptide labeled with a BODIPY-FL-C1 fluorophore at positions 12 and 26,
respectively. From an analysis of energy transfer between the different fluorescence labels and their location in the molecules,
we were able to place the Ab peptide inside GM1 micelles, close to the hydrophobic-hydrophilic interface. Large unilamellar
vesicles composed of a raftlike GM1/bSM/cholesterol lipid composition doped with labeled GM1 at various positions also interact
with labeled Ab peptide tagged to amino acids 2 or 26. A faster energy transfer was observed from the Ab peptide to bilayers
doped with 581/591-BODIPY-C11-GM1 in the nonpolar part of the lipid compared with 581/591-BODIPY-C5-GM1 residing in the
polar headgroup. These data are compatible with a clustering process of GM1 molecules, an effect that not only increases the Ab
peptide affinity, but also causes a pronounced Ab peptide penetration deeper into the lipid membrane; all these factors are
potentially involved in Ab peptide aggregate formation due to an altered ganglioside metabolism found in AD patients.INTRODUCTIONAlzheimer’s disease (AD) is the most prominent member
of the family of devastating neurodegenerative disorders
that affect millions of people worldwide (1,2). A hallmark
of these diseases is the presence of aberrantly folded protein
deposits (1,3). These proteins often have little or no sequence
homology, but their conversion from a native state into toxic
aggregates is the common feature for these disorders. There-
fore, numerous studies have focused on the identification of
the protein misfolding processes. However, the molecular
mechanisms behind the neurotoxic action of these protein
species still remain unknown.
The most studied neurodegenerative disease is AD, which
is characterized by amyloidogenic plaques, mainly contain-
ing the 39- to 42-residue amyloid-b (Ab) peptide (4). This
amphiphatic peptide is the cleavage product of the >770-
residue-long amyloid precursor protein, a single type-1 trans-
membrane protein whose function is not yet clarified (5,6).
Oligomeric aggregates of Ab peptide are assumed to be the
main culprit in AD, as shown by their toxic impact on
neuronal cells in cultures and in aged brains (1,3,7). But how
can Ab peptide undergo conversion from a soluble, nontoxic
monomer into these aggregates? Even though it is assumed
that the conversion into toxic aggregates is an intrinsic prop-
erty of the peptide (2,8), the actual folding fate is controlled
by its immediate surrounding. This environment contains
numerous cellular membranes, and these membranes areSubmitted February 24, 2010, and accepted for publication June 17, 2010.
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0006-3495/10/09/1510/10 $2.00ideal targets for the amphiphatic Ab peptide, which contains
a hydrophilic (residues 1–28) nonspecific extramembranous
part andahydrophobic helixlike transmembranepart (residue
29–40/42). The membrane anchoring ability (4,5,9) comes
from these properties.
It was shown in vitro that the presence of various target
membranes could induce accelerated aggregation of Ab-
peptide monomers into amyloidogenic aggregates (10–17),
a potential key process in AD pathology (7,18). In general,
the presence of charged lipid components induced an elec-
trostatically driven surface accumulation of Ab-peptide
monomers, followed by a much faster conversion into aggre-
gates than would occur in a membrane-free environment
(10,15,16).
Many recent studies of AD have focused on the specific
role of neuronal membranes, whose interaction with the Ab
peptide might be crucial in the onset and development of
the disease (19,20), a research hypothesis that is based on the
abundance of amyloid precursor proteins in neurons and the
pathologically altered lipid composition observed in many
AD patients (21,22). These changes were most dramatic
for the lipid family of gangliosides, which are neuronal-
membrane-specific sialic-acid-containing glycosphingoli-
pids involved in numerous neurobiological events, including
synaptic transmission (23).
Gangliosides have even been found to associate with Ab
peptide in vivo, which make them a prime suspect in path-
ological Ab peptide interactions with membranes (14,24).
The role of gangliosides in amyloidogenic diseases has been
intensely studied by a variety of approaches (11–14,24).doi: 10.1016/j.bpj.2010.06.043
Designed Fluorescent Probes 1511A connection between neuronal gangliosides and an accel-
erated aggregation of Ab peptide was monitored using a
Trp-labeled Ab(1–40) peptide (25,26). Matzusaki et al. used
fluorescence spectroscopy and specifically labeled ganglio-
sides to provide molecular insights into ganglioside-contain-
ing raftlike membranes and their role in the pathological
behavior of Ab peptides (13,27–30). It was recently demon-
strated that the monosialoganglioside GM1 released from
damaged cells can trigger the formation of Ab fibrils (29).
These fibrils are much more toxic than GM1-free fibrils.
Although it is established that gangliosides potentially
exhibit a pathological role in the aggregation of Ab peptides,
the molecular nature of the specific ganglioside interactions
with Ab peptide monomers and the subsequent lipid-peptide
assemblies during the aggregation process are not yet unrav-
eled. This is also true for the mechanism by which the Ab
peptide interacts with GM-containing membranes, either
by surface association or by insertion (27), the latter of which
might prevent aggregation inside membranes or enable the
formation of potentially toxic transmembrane ion channels
(21). However, there is no structural evidence of Ab peptides
inserted into membranes or the impact of such insertion on
the surrounding lipids. Only theoretical models exist, and
these predict a mutant-dependent partial insertion, which
might increase ion-channel formation (34). A recent simula-
tion suggests that the peptide is localized at the interface of
the membrane upon proteolytic cleavage (31). In addition,
there is even an ongoing discussion concerning the possible
role of Ab-ganglioside micellar structures as in vivo seeds
for peptide aggregation (32).
Here, fluorescence methods were used to address the
location and behavior of the Ab peptide in/at ganglioside-
containing membrane interfaces on a molecular level, as
well as fundamental differences in Ab peptide behavior upon
transfer to a micellar environment (33–35). To obtain infor-
mation regarding the spatial preference between Ab(1–40)
peptide and gangliosides in micellar and membranous
systems, the electronic energy transfer between BODIPY-
labeled Ab(1–40) peptides and BODIPY-labeled GM1 lipids
was studied. To study membrane interactions without inter-
ference, site-specificmutations within the hydrophilic region
(residues 1–28) were used, where a natural amino acid
residue was replaced by a Cys residue. This enabled the
incorporation of a sulfhydryl-specific fluorescent reporter
group. In this study, the BODIPY-FL label was covalently
attached to positions 2, 12, and 26, which represent the
initial, middle, and ending parts of the postulated hairpin
region (36,37). The studied fluorophore-labeled peptides
served as donors of electronic energy to either the 564/571-
BODIPYor the 581/591-BODIPYacceptor group, localized
in the GM1 lipid (cf. Fig. 1). For an effective energy trans-
fer, the peptide-GM1 distances must not exceed ~60 A˚. We
observed a strong affinity of Ab peptides to micelles
composed of GM1. In phosphatidylcholine (PC) bilayers con-
taining GM1, the ability of Ab to bind to the membrane isclosely correlated with the clustering of GM1 and its specific
location.MATERIALS AND METHODS
Ab(1–40) mutants with Cys in positions 2, 12, and 26 were obtained from
Alexotech (Umea˚, Sweden), with the correct molecular weight verified by
MALDI-TOF. To accomplish an efficient dissolution of all peptides before
labeling, a procedure described elsewhere (38) was used. The sulfhydryl-
specific BODIPY-FL-C1-iodoacetamide (Invitrogen, Gothenburg, Sweden)
was linked covalently, as described previously (39). Removal of free probe
was achieved by peptide precipitation in 10 volumes of 90% cold acetone.
The pellet was dissolved in hexafluoroisopropanol and upon removal was
stored as peptide film at 20C. Before use, the film was treated by the
NaOH/dimethylsulfoxide procedure described above. The degree of labeling
was determined from absorbance measurements at 280 and 505 nm.
All fluorescent BODIPY-labeled gangliosides were synthesized as
described elsewhere (40) The BODIPY-labeled fatty acids and the lipids
were purchased from Invitrogen (Carlsbad, CA) and Avanti Polar Lipids
(Alabaster, AL), respectively. The gangliosides GM1 and GD1a were isolated
from bovine brain, as described by Svennerholm (41). The chemical struc-
tures of the different BODIPY-labeled gangliosides are displayed in Fig. 1.
Exposure to light was avoided in all handling of the dyes. All solvents
used were reagent grade and freshly distilled. A Tris-HCl buffer (20 mM)
containing 1 mM EDTA disodium salt, pH 7.4, was used in all experiments
with Ab peptides, micelles, and vesicle systems.Preparation of micelles
Ganglioside GM1 spontaneously formsmicelles in water or buffer at concen-
trations above the critical micelle concentration (1 mM). In this work, the
concentrations used were 3–4 orders of magnitude higher. The concentra-
tion of BODIPY-FL-labeled Abs was ~1 mM in all experiments, as deter-
mined from spectral absorption experiments.All samples were thermostated at 20C
Technical details concerning the preparation of vesicles and the spectro-
scopic experiments are given in the Supporting Material.RESULTS AND DISCUSSION
BODIPY-FL-Ab(1–40) and micelles of GM1
Each of the BODIPY-FL-labeled mutants of the Ab(1–40)
peptide was added to GM1 micelles, which were doped with
the 581/591-BODIPY- or 564/570-BODIPY-labeled gangli-
oside. The location of these fluorescent groups in the gangli-
oside molecule (Fig. 1) strongly suggests that the fluorescent
moieties of the C5-GM1 and C11-GM1 molecules are located
in the polar and nonpolar parts of a lipid bilayer, respec-
tively. Upon interaction of BODIPY-FL-labeled Ab peptides
with the micelles, the labeled gangliosides act as acceptors
of electronic energy from the donor group BODIPY-FL
located in Ab peptides. Different combinations of donor and
acceptor pairs were studied using steady-state and time-
resolved fluorescence spectroscopy. The obtained results
exhibit very similar patterns. Interactions between the
BODIPY-FL-labeled Ab peptide and micelles are evident
from the observed increase of the labeled GM1 fluorescenceBiophysical Journal 99(5) 1510–1519
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1. 564/570-BODIPY-C5-GM1, polar-labelled
2. 564/570-BODIPY-C5-GM1, non-polar-labelled
3. 581/591-BODIPY-C5-GM1, polar-labelled
4. 581/591-BODIPY-C11-GM1, non-polar-labelled
5. 564/570-BODIPY-C5-Asialo-GM1, non-polar-labelled
,
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FIGURE 1 Chemical structures of the BODIPY-
labeled gangliosides GM1(1–4) and the BODIPY-
labeled Asialo-ganglioside GM1(5).
1512 Mikhalyov et al.upon the excitation of BODIPY-FL (Fig. 2). Electronic
energy transfer from theBODIPY-FL-labeledpeptide (donor)
to the 581/591-BODIPY-labeled GM1 (acceptor) explains the
relative increase of the fluorescence intensity observed for
the latter. Changes of the physicochemical properties in the
vicinity of the BODIPY moiety upon addition of micelles
to the peptides in water buffer, are indicated by a red shift
of the BODIPY-FL absorption spectrum.
To estimate any potential influence of the BODIPY groups
attached to lipids, additional experiments were carried out
with micelles containing reduced fractions of acceptor-
labeled GM1. In these experiments, the Cys
26-mutated Ab
peptide labeled with BODIPY-FL was used, whereas the
micelles were doped with 564/570-BODIPY-C5-GM1 at a
molar ratio of 1 probe-GM1/3000 GM1 molecules. This cor-
responds to approximately one 564/570-BODIPY-C5-GM1
molecule/18 micelles. Upon addition of micelles to theBiophysical Journal 99(5) 1510–1519BODIPY-FL-Ab peptide, the pattern observed was very
similar to that shown in Fig. 2. That is, the fluorescence
steady-state anisotropy of the peptide increases rapidly and
the fluorescence band of the acceptor 581/591-BODIPY-C5-
GM1 appears.
In addition, to elucidate any influence of the gangliosides
on the studied interactions, micelles composed of the GD1a
were also prepared. The negatively charged BODIPY-
labeled GM1 was replaced with electrically neutral 564/
570-BODIPY-C5-Asialo-GM1. The interaction between
BODIPY-FL-labeled Ab peptides and 564/570-BODIPY-
C5-Asialo-GM1 in GD1a micelles reveals the same pattern
as that obtained for GM1 micelles. Thus, the observed inter-
actions are caused neither by specific interactions with the
GM1 lipid nor by specific interactions between the charged
labeled lipid (564/570-BODIPY-C5-GM1) and the Ab
peptide.
AB
FIGURE 2 Fluorescence spectra (A) and fluorescence steady-state
anisotropy, r (B) of BODIPY-FL-Ab-Cys12, 0.45 mM in 20 mM Tris-HCl
buffer, pH 7.4 (1 and 5, respectively) and with GM1 micelles containing
581/591-BODIPY-C5-GM1 (1 mol %), 1:20 mol/mol (2 and 6, respectively),
1:120 mol/mol (3 and 7, respectively), and 1:240 mol/mol (4 and 8, respec-
tively). The excitation wavelength was 470 nm.
FIGURE 3 Steady-state fluorescence anisotropy (r) of BODIPY-FL-Ab-
Cys12, 0.45 mM in Tris-HCl buffer, pH 7.4 with GM1 micelles, containing
1 mol % of 581/591-BODIPY-C5- GM1 (open symbols) and -C11-GM1 (solid
symbols) in the range 500–575 nm (circles) and 590–660 nm (triangles).
The excitation wavelength was 470 nm.
Designed Fluorescent Probes 1513Fluorescence depolarization in the absence
of energy transfer
Time-resolved and steady-state fluorescence depolarization
experiments were performed on BODIPY-FL-Cys26-Ab
upon interactions with GM1 micelles that did not contain any
acceptor-labeled gangliosides. Here, the acronym BODIPY-
FL-Cys26-Ab stands for the Cys26 mutant of the Ab(1–40)
peptide, which is labeled by a sulfhydryl-specific BODIPY-
FL reagent. The studied molar ratios of GM1/BODIPY-FL-
Cys26-Abwere 325:1, 50:1, and 25:1, for which the obtained
steady-state anisotropy values were 0.239, 0.162, and 0.124,
respectively. Using the recently determined value for the
micellar GM1 aggregation number (1685 4) (40), the above
ratios correspond to average numbers of peptides/micelle
of 0.51, 3.4, and 6.7, respectively. In the absence of micelles,
the steady-state anisotropy of the peptide is much lower,
typically ~0.06 (vide infra). Therefore, the much higher
anisotropy values suggest an efficient association of the
peptide molecules to the micelles, a conclusion further sup-
ported by the results presented in the following subsections.
The lowered anisotropy values obtained with increasingnumbers of peptides per micelles can be explained by an
increasing rate in electronic energy migration among the
BODIPY-FL groups in the micelles. For the most diluted
system (1:350), however, it is reasonable to neglect the influ-
ence of energy migration. This implies that the steady-state
and time-resolved anisotropy are determined by the reorien-
tational motions and local order of the BODIPY-FL group
(43). Fromanalyses of these data, an average rotational corre-
lation time of 12.1 ns is obtained. The influence of micellar
rotational motion is negligible on the studied fluorescence
timescale, since the rotational correlation time of a GM1
micelle is ~50–60 ns. The negligibility of this influence is
also supported by the residual nonzero anisotropy in the
decay of the fluorescence anisotropy. Therefore, the obtained
average correlation time can be ascribed to local reorienting
motions of theBODIPY-FL group in theGM1micelle. A local
order parameter value of 0.66 was calculated from the
residual nonzero anisotropy. The high value of the order
parameter is compatible with a rather restricted orientation
of the BODIPY group.Fluorescence depolarization and energy transfer
Interactions between Ab peptides and GM1 micelles are
evident from fluorescence depolarization experiments, from
which the calculated emission anisotropies (cf. Figs. 2 and
3) were calculated. The anisotropy value of BODIPY-FL-
Cys12-Ab in buffer is rather low, ~0.06. Using this value
and the measured fluorescence lifetime of 4.6 ns, an effec-
tive reorientation correlation time of the BODIPY group can
be estimated to be ~1 ns. Assuming that the peptide reor-
ients like a spherical particle, and by using the molecular
mass of the BODIPY-FL-Cys12-Ab (i.e., ~4500 Da), the
calculated rotational correlation time is ~4 ns. The obtained
shorter correlation time is, however, compatible with a
flexible peptide structure (9), as well as rapid internalBiophysical Journal 99(5) 1510–1519
1514 Mikhalyov et al.reorientations of the BODIPY group. The steady-state
anisotropy of the BODIPY-FL group increases upon adding
GM1 micelles, as well as upon increasing the molar ratios
between the GM1- and BODIPY-FL-labeled Ab peptide (cf.
Fig. 3). The steady-state anisotropy increases to a maximum
value of r z 0.24 for ratios of ~250:1, which corresponds
to an average number of 0.7 Ab peptides/micelle. The
concentration range studied corresponds to an average
number of ~1–8 peptides/micelle. In these experiments,
the concentration of the BODIPY-FL-Cys12-Ab was kept
constant (0.45 mM), whereas the micelle concentration was
varied. The average fluorescence lifetime of BODIPY-FL
increases slightly, with increasing micelle concentration.
Upon association between BODIPY-FL-labeled Ab peptides
and micelles, the reorienting rates of the BODIPY-FL group
should become slower. Thus, higher anisotropy values are
expected and also observed (cf. previous subsection).Micellar bulk phase distributions of BODIPY-
labeled GM1 and BODIPY-FL-labeled Ab peptides
In all experiments, the fraction of BODIPY-labeled GM1 in
the micelles was 1 mol % of the total lipid content. Since
previous studies have revealed no preferential affinity
between BODIPY-labeled and nonlabeled GM1 (34), a Pois-
sonian distribution of the BODIPY-labeled GM1 can be
assumed for calculating the probability of finding 0, 1, 2,
or more peptides in a micelle. These probabilities are
denoted by P0, P1, P2, . . With knowledge of the average
number of BODIPY-labeled GM1 molecules/micelle (hni),
the probability of finding an empty micelle is given by
P0 ¼ expðhniÞ. In our particular case, hni ¼ 1:68, which
corresponds to the probability ofP0 ¼ 0:186. Thus, the prob-
ability of finding micelles populated by at least one acceptor
(A ¼ BODIPY-labeled GM1) is given by PR1A ¼ 1 P0 ¼
0:814. For electronic energy transfer between a BODIPY-FL
group and the acceptor 581/591-BODIPY group connected
with GM1, the Fo¨rster radius is 60 A˚ (34). Since the hydro-
dynamic radius of a GM1 micelle is 54 A˚ (40), a substantial
probability is given for the electronic energy transfer from
a BODIPY-FL-labeled Ab peptide, localized, for instance, at
the micellar surface, to a 581/591-BODIPY-labeled GM1.
The probability of finding one acceptor/micelle is P1 ¼
0.313. Taken together, one concludes that the probability
of finding at least two acceptors/micelle in the presence of
1 mol % labeled GM1 is 0.5. For electronic energy migration
among 581/591-BODIPY groups connected with GM1, the
Fo¨rster radius is 68 A˚ (34). Therefore, energy migration
among 581/591-BODIPY groups is highly probable within
50% of the micelles. We assume now also a Poissonian
peptide distribution among the micelles, and that the bulk-
phase concentration is negligible. The studied molar ratio
between BODIPY-FL-labeled Ab peptides and micelles
typically ranges from 1 to 8. Under these conditions, the
probability of finding at least one peptide (donor (D))/micelleBiophysical Journal 99(5) 1510–1519(PR1D) is limited to 0:65%PR1D%1. Thus, the joint proba-
bility of finding at least one donor and one acceptor localized
in a micelle varies between 0.52 and 0.81 for the systems
investigated. As is shown in the next section, hardly any
dependence on the molar ratio of peptide to micelle is
found. This is compatible with a strong affinity for peptide
association to GM1 micelles.Fluorescence lifetime and intensity data
The fluorescence lifetime of BODIPY-FL-Ab peptides and
labeled GM1 lipids was measured by means of the time-
correlated single-photon counting technique. For different
mixtures of lipid systems and differently labeled peptides,
the mean lifetimes of the donor and the acceptors were cal-
culated from the fluorescence decays, which were collected
under the magic-angle condition (44). The mean lifetime
of the donor increases very weakly with decreasing mole
fraction of the BODIPY-FL-Ab-peptide. For instance, the
average lifetime of BODIPY-FL-Cys12-Ab increases from
4.5 to 5.0 ns upon decreasing the mole fraction from 1:20
to 1:240 in a micelle labeled with 581/591-BODIPY-C5-
GM1. This is compatible with electronic energy transfer, as
well as with the presence of excitation traps formed by
possible dimerization of BODIPY-FL groups at high local
concentrations (45). The fluorescence decay of the acceptor,
581/591-BODIPY-C5-GM1, is biexponential, with one preex-
ponential factor being negative, as expected in the presence
of donor-acceptor energy transfer. Actually, this proves that
581/591-BODIPY-C5-GM1 molecules are indirectly excited
via electronic energy transfer from the donor groups. For
pure GM1 micelles (i.e., without any labeled GM1), the mean
lifetime decreases for the lowest concentrations of micelles,
that is, for the highest number of peptides/micelle. There are
two possible explanations for this: either a quenching
process due to the formation of ground-state dimers of BOD-
IPY-FL (45) or/and partial donor-donor energy migration
(46). For instance, dimer formation cannot be excluded at
the BODIPY-FL-Cys12-Ab/GM1 molar ratio of 1:50, since
this corresponds to 5–6 peptides/micelle. On the other hand,
the fluorescence (i.e., the photophysics) relaxation of the
BODIPY-FL-Cys12-Ab is not a monoexponential function
and the Fo¨rster radius of energy migration among BODIPY-
FL groups is 58 A˚ (47). Therefore, partial donor-donor
energy migration within a micelle will reduce the observed
mean lifetime upon an increase in the number of peptide
molecules.
The corrected fluorescence spectra obtained for different
molar ratios of BODIPY-FL-Cys12-Ab and GM1 micelles,
doped with the acceptor 581/591-BODIPY are shown in
Fig. 2. The efficiency of donor-acceptor energy transfer can be
characterized by the intensity ratio ~FA ¼ FAðlmaxÞ=FDðl0maxÞ,
where FDðl0maxÞand FAðlmaxÞ denote the peak fluorescence
of the donor and acceptor groups. The calculated values of
~FA and the probability of finding more than one peptide per
FIGURE 4 The ratio (~F
Cn
) between the fluorescence intensities of
acceptor (FA) and donor (FD) plotted versus the probability of finding at
least one donor molecule (BODIPY-FL-Cys12-Ab) in a GM1 micelle. The
acceptors are 581/591-C5-BODIPY-GM1 (black inverted triangles) and
581/591-C11-BODIPY-GM1 (gray triangles) labeled in the hydrophilic
and the hydrophobic parts, respectively, of GM1. The acceptor concentration
is kept constant at 1 mol % of the total lipid content.
Designed Fluorescent Probes 1515micelle (PR1D) for different donor/acceptor molar ratios
are displayed in Fig. 4. For each of the acceptor molecules,
581/591-BODIPY-C5-GM1 and 581/591-BODIPY-C11-GM1,
the ~FA dependence on PR1Dis weak and the two distinct
~FA levels obtained are ~F
C5
A ¼ 0.8 and ~F
C11
A ¼ 1.1, respectively.
A reasonable explanation for the distinct levels reached for
probabilities PR1D< 0.8 is that most peptide molecules are
associatedwithmicelles, i.e., a negligible fraction of peptides
are residing in the bulk phase. Note that the ~F
C5
A and
~F
C11
A
values decrease for probabilities PR1D> 0.8, which corre-
sponds to an average number of three or more peptide mole-
cules/micelle. This is compatible with an increased distance
between the surfaces of the micelles and the peptides due to
the peptidemolecule size, whereby the rate of energy transfer
would decrease. However, self-quenching of the BODIPY-
FL groups at higher concentrations is a more likely explana-
tion (45) and is also supported by the shortened lifetimes
observed for BODIPY-FL-Cys12-Ab in nonlabeled GM1
micelles. In a simplified description, ~FA can be modeled
according to
~FAf
RN
0
PAðtÞdt
RN
0
PDðtÞdt
¼ utD; (1)
where PDðtÞ and PAðtÞstand for the time-dependent excita-
tion probabilities of the donor and the acceptor, obtained
by solving the master equation of electronic energy transfer
probability (48). Furthermore, tD and u denote the donor
fluorescence lifetime in the absence of energy transfer and
the effective rate of energy transfer, respectively. The plateau
values of ~F
C5
A and
~F
C11
A inserted into Eq. 1 imply that
uC11 > uC5, since tC11A xt
C5
A . This means that the energytransfer from the BODIPY-FL-Cys12-Ab peptide is 37.5%
faster to a 581/591-BODIPY-C11-GM1 molecule. The effec-
tive transfer rate depends on spatially (R) and orientationally
distributed donor-acceptor pairs according to
u ¼ 3hk
2i
2tD
R60
R6
; (2)
where R0 and hk2i stand for the Fo¨rster radius and the mean-
squared orientation dependence of dipole-dipole coupling,
respectively. For the studied donor-acceptor pairs, the value
of R0 is the same. For spherical micelles, it is reasonable
to assume that hk2iC5 ¼ hk2iC11, whereby one obtains
hR6iC5=hR6iC11 ¼ 1:375. For donor-acceptor groups at a
fixed distance (i.e., for a dðR ¼ RCnDAÞ distribution), this corre-
sponds toRC5DA ¼ 1:05RC11DA .What are the average locations of
the BODIPY-FL group in Cys12-Ab that would correspond
to the observed higher transfer rate to the 581/591-BODIPY
group, which is covalently attached to the C11 in the GM1? By
inspecting the chemical structure of the GM1 derivatives
labeled in the headgroup (C5) and in the acyl chain (C11)
together with the known radius of amicelle, one can estimate
the distances from the center of a micelle to RC11 ¼ 9 Aand
RC5 ¼ 27 A, respectively. The obtained average radial
distance from the micellar center to the BODIPY-FL group
of Cys12-Ab is 32 A˚. This value was calculated using the
model described in the Supporting Material.
In addition, the transfer rate between the BODIPY-FL-
Cys26-Ab-labeled peptide and the 581/591-BODIPY-
C5-GM1 was studied. The obtained rate (u
C5
C26Ab) has been
compared to that between BODIPY-FL-Cys12-Ab labeled
peptide and the 581/591-BODIPY-C5-GM1 (u
C5
C12Ab). From
the ratio of uC5C26Ab=u
C5
C12Ab ¼ 1:43, the distance between the
BODIPY-FL group of Cys26-Ab and the center of a micelle
can be calculated by using Eq. S3 in the Supporting Mate-
rial. Two possible solutions are found, which correspond
to distances of 5.6 and 46.7 A˚. These distances imply a radial
displacement of 26.4 or 14.7 A˚ between the BODIPY-FL
groups attached to mutants Cys12-Ab and Cys26-Ab.BODIPY-FL-Ab(1–40) and vesicles containing GM1
We also examined potential interactions between BODIPY-
FL-amyloid-b-peptides and large unilamellar vesicles
(LUVs) of composition GM1/bSM/Chol ¼ 30:40:30 (mol %).
In three separate preparations, vesicles were doped with
0.3 mol % of 581/591-BODIPY-C5-GM1, 581/591-BODIPY-
C11-GM1, and 564/571-BODIPY-C5-GM1. In the first and
last cases, the BODIPY-FL group is localized in the polar
part of the lipid bilayer. This was done with 581/591-
BODIPY-C11-GM1, with the fluorophore residing in the non-
polar region. Within a week after the addition of BODIPY-
FL-Cys2-Ab and -Cys26-Ab to the LUVs, electronic energy
transfer was observed from the BODIPY-FL-labeled peptide
to each of the labeled GM1 lipids (Fig. 5). In contrast to theBiophysical Journal 99(5) 1510–1519
AB
FIGURE 5 Fluorescence spectra (A) and steady-state fluorescence aniso-
tropy, r (B) of BODIPY-FL-Cys2-Ab, 5 mM in Tris-HCl buffer, pH 7.4
(1 and 5, respectively) and of LUV:s composed of GM1/bSM/Chol at molar
ratio 3:4:3 (250 mMGM1) unlabeled (2 and 6, respectively), and doped with
0.3 mol % 581/591-BODIPY-C5-GM1 (3 and 7, respectively) and 581/591-
BODIPY-C11-GM1 (4 and 8, respectively). The excitation wavelength was
470 nm.
1516 Mikhalyov et al.studies of GM1 micelles, no significant red shift was
observed in the absorption spectra of BODIPY-FL-labeled
peptides. It is interesting that a higher efficiency of energy
transfer (~FA) was observed from BODIPY-FL-Cys
2-Ab to
the nonpolar labeled 581/591-BODIPY-C11-GM1 than to the
polar-labeled 581/591-BODIPY-C5-GM1. The decrease in
BODIPY-FL emission and the increase in 581/591-BODIPY
emission were stronger for the acceptor localized in the
nonpolar region (cf. Fig. 5). This observation indicates a
penetration of the Ab peptide into the lipid bilayer of the
studied LUV. A penetration is also revealed by the transfer
efficiencies obtained for BODIPY-FL-Cys26-Ab. Further-
more, these observations indicate shorter average distances
from the labels in the 2nd and 26th positions of the peptide
to the acceptor localized in the nonpolar part of the gangli-
oside compared to the acceptors localized in the polar
region. Therefore, the efficiency of energy transfer (i.e.,
the ~FA values) for the studied positions were analyzed by
a model similar to that used for the GM1 vesicles. However,
the values obtained were unphysical for distances between
the center of the lipid bilayer and the labeling positions.Biophysical Journal 99(5) 1510–1519This can be expected if the mutual lateral distribution of the
peptides and/or the lipid components is nonrandom. Since
the transfer efficiency was greater for BODIPY-FL-Cys2-Ab
than for BODIPY-FL-Cys26-Ab, the former residue appears
to be located closer to the acceptor connected with the
hydrophobic ganglioside region.
As seen here, the presence of gangliosides in the lipid
membranes has major consequences for the behavior of the
Ab peptide. Normally, the peptide does not penetrate into
bilayers composed of simple mixed phospholipids, such as
phosphatidylcholine/phosphatidylglycerol, but prefers the
surface region, as various biophysical studies suggest (9,16).
However, the presence of charged gangliosides, with their
specific headgroup regions, enables the peptide to pass the
membrane surface barrier and partially penetrate into the
membrane interior. This behavior is not unusual, as has been
indicated by earlier work on ganglioside-containing lipid
systems (9–16), as well as from molecular dynamics simu-
lations (49). Therefore, it is clear that upon release of the Ab
peptide in vivo into a membrane-free aqueous environment,
it still can reinsert itself into membranes if in contact with
target membranes containing ganglioside. As indicated by
our experiments, there seems to be a two-step mechanism.
In the first step, the peptide can bind to the membrane
surface, a process severely enhanced by a clustering of the
gangliosides in phosphatidylcholine lipid membranes, as
discussed further below. In the second step, the surface-
adsorbed peptide molecules can penetrate partially into the
neuronal membrane system, as indicated by our fluorescence
data.
In LUVs, the steady-state anisotropy of the BODIPY-FL
group in Ab is relatively low compared to the values found
for GM1 micelles. Even in the absence of labeled GM1, one
obtained low and very similar anisotropy values. Addition
of the detergent Triton X-100 converted vesicles into mixed
micelles (50). As a consequence, the peptide molecules
were distributed over many micelles, a process that should
decrease the influence of energy transfer, whereas the fluo-
rescence anisotropy of the BODIPY-FL group in Ab should
increase. However, it turns out that the anisotropy was not
reaching the same high level as in the experiments carried
out with GM1 micelles, as illustrated in Fig. 6. Taken
together, these results clearly suggest different spatial distri-
butions of the peptides in a water-lipid interface of GM1
micelles, as compared to mixed micelles formed by Triton
X-100 solubilization of lipid vesicles.A comparison between Ab interactions with
micelles and lipid bilayers
It has been suggested that charged lipids are needed to bind
the Ab peptide to the lipid surface (10,16). In this work,
energy-transfer experiments clearly reveal strong interac-
tions between Ab peptides and GM1 micelles, in agreement
with previous studies (51). Yanagisawa et al. (51) assumed
AB
FIGURE 6 (A) Fluorescence spectra of BODIPY-FL-Cys26-Ab, 4 mM in
Tris-HCl buffer, pH 7.4 (1), directly after addition of LUVs composed of
GM1/bSM/Chol in the molar ratio 3:4:3 (470 mM GM1) and containing
0.6 mol % 564/571-BODIPY-C5-GM1 (2), after 6 days incubation (3), and
after addition of Triton X-100 (4). (B) Steady-state fluorescence anisotropy,
r, of systems 2–4 in A. The excitation wavelength was 470 nm.
FIGURE 7 Schematic illustration of the Ab peptide position in GM1
micelles. A space-filling model of the ganglioside GM1 is indicated in the
segmental volume of a spherical micelle. The hydrodynamic radius of the
micelle is 54 A˚, and the radial distance between the BODIPY-FL groups,
indicated by the green spheres labeled C12 and C26, is 15 A˚.
Designed Fluorescent Probes 1517that the peptides form aggregates in solution, and that these
aggregates are destroyed by the presence of GM1 micelles. It
is likely that the peptides can incorporate into the micelles
themselves, a process that would be consistent with the
observed changes in energy transfer and steady-state anisot-
ropy of the BODIPY-FL-labeled Ab peptide. Upon incorpo-
ration of the peptides, the rate of energy transfer reaches
a maximum, whereas the rate decreases upon further addi-
tion of micelles, because the number of peptides per micelle
decreases. This is very similar to the results obtained for the
same peptide with GM1 micelles in the absence of labeled
GM1 lipids. From our analysis of the obtained energy-trans-
fer data, it is possible to position the BODIPY-FL groups of
the Ab-peptide in GM1 micelles. The most probable locali-
zation (Fig. 7) has been derived from distances calculated
between the center of a micelle and the BODIPY-FL groups,
as well as from structural data obtained from NMR experi-
ments with the Ab peptide in micellar systems (52–55). In
contrast to the behavior of the Ab peptide in micelles of
sodium dodecyl sulfate (SDS), with its small hydrophilic
interface (52,55), the peptide in GM1 micelles is located
much deeper. This can be ascribed to the thick hydrophilicregion (~27 A˚) of GM1 micelles, which is created by the vol-
uminous carbohydrate lipid headgroups. In this region, there
is enough space to locate the hydrophilic N-terminus,
whereas in SDS micelles this part already extends into the
aqueous environment (52). The first helix is still part of the
extramembranous segment (1–28) of Ab peptide and is
therefore, not surprisingly, oriented toward the more polar
part of the headgroup region, in agreement with our mea-
surements. Additional support for this positioning of the
peptide was recently obtained from NMR studies using lyso-
GM1 micelles (53,54). The results strongly suggest peptide-
induced changes of the NMR signals from the carbohydrate
region, which indicate perturbations exactly in the area
where our peptide is located. Supplementary NMR experi-
ments using labeled peptide in these micelles provided a
more molecular view of these perturbations (54). Moreover,
the type of up-and-down topology they observed is reflected
in our model, where the hydrophobic, helical part of the
peptide is pointing toward the more hydrophobic center of
the micelle. Recent MD simulations on the structure of the
Ab(1–40) peptide in model membranes reflect a similar
location and topology at the interface (31). Nevertheless,
because of the smaller interface region in these membranes
and in SDS micelles, the hydrophobic parts of the peptides
are positioned deeper in the hydrophobic membrane region,
as compared to GM1 micelles, with their much larger carbo-
hydrate region and less steep gradient from hydrophobic to
hydrophilic environment.
The interactions between the Ab peptide and bilayers of
LUVs appear more complex compared to ganglioside
micelles. Despite the presence of negatively charged phos-
phatidylglycerol in bilayers (composed of DOPC/DOPG
at a molar ratio of 2:1), no energy transfer was observed.
For this composition, however, Matsuzaki et al. (28) have
reported interactions with Ab peptides. On the other hand,
no interaction was reported for the composition ofBiophysical Journal 99(5) 1510–1519
1518 Mikhalyov et al.DOPC/GM1 ¼ 10:1 (molar ratio) (13). The same report also
claimed that the Ab peptide interacts with GM1/bSM/Chol¼
20:64:16 (mol %). In the study presented here, no interac-
tions were observed for the latter mixture. However, upon
addition of GM1 to lipid bilayers composed of GM1/bSM/
Chol ¼ 30:40:30 (mol %), energy transfer was observed
from Ab peptides to the labeled GM1, accompanied by
a small increase in the steady-state anisotropy of the Ab
peptide. This is compatible with an increased reorientational
restriction of the peptide.
For a comparison among the different observed inter-
actions between Ab peptide and micelles or LUVs, the
average surface density of the peptide in the membrane was
estimated. By using the hydrodynamic GM1 micellar radius
of 5.4 nm (40), one obtains an average surface area of
42,250 A˚2/micelle. The average aggregation number, i.e.,
the number of GM1 molecules that form a micelle, is 167
(40). Considering the studies of interactions between Ab
peptide and GM1 micelles for peptide/ganglioside molar
ratios ranging between 1:20 and 1:240, the average surface
density lies within the range of one peptide per 4970–
60,360 A˚2. For the LUV system studied, the corresponding
surface density is 9380 A˚2/peptide. Note that these numbers
are based on the assumption of a random distribution of pep-
tides on the surface. However, the steady-state emission
anisotropy of the BODIPY-FL-labeled Ab peptide is much
lower in interactions with LUVs (0.044) than in those with
GM1 micelles (0.127). The anisotropy value obtained for the
LUV system is very similar to that obtained for the peptide
in bulk solution, i.e., in the absence of vesicles. Such an effi-
cient depolarization is not expected if the peptides are asso-
ciated with the lipid surface as they are for micelles. This
reduction in anisotropy can be ascribed to a more efficient
energy migration, which is possible if gangliosides tend to
cluster in the bilayer. Therefore, the mean distance between
the BODIPY-FL groups becomes shorter, whereby a more
rapid energy migration occurs and a lower anisotropy should
be obtained.
As our results show, gangliosides as important neuronal
membrane compounds exert interactions with Ab peptides
quite differently from common membrane-forming lipids,
e.g., phosphatidylserines. The nature of this specific gangli-
oside-Ab-peptide interplay might therefore be crucial in AD
accompanying aggregate formation in humans, caused by
alterations in ganglioside metabolism that are age- and/or
disease-related.SUPPORTING MATERIAL
Materials and one figure are available at http://www.biophysj.org/biophysj/
supplemental/S0006-3495(10)00786-1.
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